IAIM
OCUL icon

International Assets Investment Management’s Ocular Therapeutix OCUL Stock Holding History

International Assets Investment Management’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18K Buy
1,900
+500
+36% +$4.53K ﹤0.01% 1648
2026
Q1 		$11.7K Buy
+1,400
New +$13.3K ﹤0.01% 1645

Other funds holding OCUL

DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
ELI
Empire Life Investments Toronto, Ontario, Canada $1.79B AUM 38.49% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
EOJOAM
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return
WB
WesBanco Bank Wheeling, West Virginia $4.02B AUM 32.62% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
KIA
Kraematon Investment Advisors Braintree, Massachusetts $134M AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

International Assets Investment Management's OCUL Position: Q2 2026 in Review

International Assets Investment Management increased its Ocular Therapeutix (OCUL) stake by 36% in Q2 2026, buying an estimated $4.53K and bringing the position to 1,900 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #1648.

International Assets Investment Management first reported a position in OCUL in Q1 2026 and has held it in 2 quarters since. 48 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • International Assets Investment Management held 1,900 shares of Ocular Therapeutix worth $18K as of Q2 2026.
  • International Assets Investment Management bought 500 Ocular Therapeutix shares in Q2 2026, an estimated $4.53K.
  • Ocular Therapeutix made up ﹤0.01% of International Assets Investment Management's portfolio in Q2 2026, its #1648 holding.
  • International Assets Investment Management first reported a position in Ocular Therapeutix in Q1 2026 and has held it in 2 quarters since.
  • 48 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.